Taking Credit (Best's Review)
The predictive power of credit behavior data can accelerate the underwriting process for life insurers.
How ‘Critical’ is Low Risk Prostate Cancer?
Insurers design critical illness policies with the intention being to cover medical conditions that are likely to have a life-changing impact on the life insured, with payment alleviating financial pressure as recovery and adjustment to an altered way of life take place. Should insurers include lower risk prostate cancer in such products or are they well positioned to exclude these altogether, considering the favorable outcome?
Impaired Risk Review: Rage Against the Machine
Increasingly, computer templates are making binding underwriting decisions through information that is programmed in with final decisions virtually unappealable. It’s a frustrating situation that is taking the human element out of a very human situation of health and risk assessment.
Industry Directions - Our Annual Forecast (LOMA Resource)
Insurance leaders predict what’s ahead for sales and profits, information technology, customer service, human capital—and more.
Collaboration Can Bring Digital Innovation to Life Insurance
There is a view that the life insurance business needs to change or to innovate in order to remain relevant and reach new customers; if incumbent players don’t make an environment that appeals to new customers, someone else will step in and do it in their place.
Cost-Benefit Analysis of Underwriting Screening for Opioid Risks
The question we hear from underwriters is: is it financially feasible to screen all life applicants for opioid use? The intention of this paper is to provide context for these concerns by exploring various screening options, and to provide a cost-benefit analysis that can assist underwriting departments in determining when to use such screening tools.
Synthesis Analysis - A Robust Statistical Tool for Life Insurance Underwriting and Pricing Research
As life insurers move toward accelerated or low friction underwriting, there is an increased interest in adopting emerging mortality risk prediction scores that are available almost instantaneously.
The 2017 Clinical Practice Guidelines for Hypertension: What Underwriters Should Know
The American College of Cardiology and The American Heart Association published the new “2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” on November 13, 2017. The new guidelines propose lower thresholds for diagnosing and lower goals for treating hypertension than the previous recommendations of 2003, especially for individuals at high risk for adverse future cardiovascular events.